Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | G6PD | P11413 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.43 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | FYN | P06241 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CA3 | P07451 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL638619 | 1.00 | G6PD (0.52) | G6PDALDH1A1HPGDHSD17B10BCL2L1 | |
| SCHEMBL9151925 | 0.89 | G6PD (0.44) | G6PDALDH1A1MAPTSMN1; SMN2LMNA | |
| SCHEMBL9244138 | 0.81 | G6PD (0.68) | G6PDALDH1A1HPGDHSD17B10MAPT | |
| SCHEMBL7864040 | 0.81 | ELANE (0.43) | G6PDALDH1A1HPGDMAPTSMN1; SMN2 | |
| SCHEMBL7868081 | 0.80 | MAOA (0.46) | G6PDALDH1A1HPGDHSD17B10MAPT | |
| SCHEMBL7865644 | 0.80 | MAOA (0.49) | G6PDALDH1A1HPGDHSD17B10MAPT | |
| SCHEMBL7865349 | 0.80 | MAPT (0.42) | G6PDALDH1A1HPGDHSD17B10MAPT | |
| SCHEMBL29700406 | 0.79 | G6PD (0.48) | G6PDALDH1A1HPGDHSD17B10BCL2L1 | |
| SCHEMBL10639950 | 0.77 | ALDH1A1 (0.41) | G6PDALDH1A1HPGDHSD17B10BCL2L1 | |
| SCHEMBL7862808 | 0.76 | G6PD (0.41) | G6PDALDH1A1HPGDHSD17B10MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12605429-B2 | Proteins having pneumococcal capsule degrading activity and methods of use | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2026-04-21 | — | — | US | disclosed |
| US-20240024435-A1 | PROTEINS HAVING PNEUMOCOCCAL CAPSULE DEGRADING ACTIVITY AND METHODS OF USE | UNIV GEORGIA (US) | 2024-01-25 | — | — | US | disclosed |
| US-11690900-B2 | Proteins having pneumococcal capsule degrading activity and methods of use | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2023-07-04 | — | — | US | disclosed |
| CN-116113436-A | Systems and methods for protecting nucleic acid molecules | 斯坦福大学托管董事会 | 2023-05-12 | — | — | CN | disclosed |
| EP-4110397-A1 | SYSTEMS AND METHODS FOR PROTECTING NUCLEIC-ACID MOLECULES | The Board of Trustees of the Leland Stanford Junior University (US) | 2023-01-04 | — | — | EP | disclosed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| CN-111372448-B | Proteins having pneumococcal capsular degradation activity and methods of use | 乔治亚大学研究基金公司 | 2022-09-16 | — | — | CN | disclosed |
| CN-110683940-B | Method for converting dibenzo [ c, e ] [1,2] oxathiane-6-oxide compound | 中国科学院成都生物研究所 | 2022-07-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12605429-B2 | Proteins having pneumococcal capsule degrading activity and methods of use | NANS, RNGTT, PNISR | G6PD 1144/4885ALDH1A1 4777/4885HPGD 3351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.